Patents by Inventor Carl A. K. Borrebaeck

Carl A. K. Borrebaeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell line and uses thereof
    Patent number: 11815509
    Abstract: The present invention provides a non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875, and methods and kits utilising such cells.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: November 14, 2023
    Assignee: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A K Borrebaeck, Henrik Johansson, Robin Gradin
  • NOVEL CELL LINE AND USES THEREOF
    Publication number: 20220178913
    Abstract: The present invention provides a non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875, and methods and kits utilising such cells.
    Type: Application
    Filed: September 24, 2018
    Publication date: June 9, 2022
    Inventors: Malin Marie Lindstedt, Carl A K Borrebaeck, Henrik Johansson, Robin Gradin
  • Analytical methods and arrays for use in the same
    Patent number: 11324787
    Abstract: The present invention relates to a method for identifying the skin sensitizer potency of a test agent, and arrays and analytical kits for use in such methods.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: May 10, 2022
    Assignee: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A. K. Borrebaeck, Henrik Johansson, Ann-Sofie Albrekt, Kathrin Stephanie Zeller, Aakash Chawade, Tim Carl Sewe Lindberg, Andy Andreas Sebastian Forreryd
  • ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
    Publication number: 20190083556
    Abstract: The present invention relates to a method for identifying the skin sensitizer potency of a test agent, and arrays and analytical kits for use in such methods.
    Type: Application
    Filed: March 22, 2017
    Publication date: March 21, 2019
    Applicant: SENZAGEN AB
    Inventors: Malin Marie Lindstedt, Carl A.K. Borrebaeck, Henrik Johansson, Ann-Sofie Albrekt, Kathrin Stephanie Zeller, Aakash Chawade, Tim Carl Sewe Lindberg, Andy Andreas Sebastian Forreryd
  • Analytical Methods and Arrays for Use in the Same
    Publication number: 20170285010
    Abstract: The present invention relates to a method for identifying agents capable of inducing respiratory sensitization in a mammal and arrays and diagnostic kits for use in such methods. In particular, the methods include measurement of the expression of the biomarkers listed in Table A(i), Table A(ii) and/or Table A(iii) in cells exposed to a test agent.
    Type: Application
    Filed: November 27, 2015
    Publication date: October 5, 2017
    Inventors: Malin Lindstedt, Carl A.K. Borrebaeck, Henrik Johansson, Ann-Sofie Albrekt, Andrew Forreryd
  • Method of selecting specific bacteriophages
    Patent number: 6027930
    Abstract: An improved method for selecting a molecule such as an antibody, antigen, peptide, protein or fragment thereof and its encoding sequence, which molecule is expressed together with a phage coat protein on the phages surface. The improvement is achieved through a new mutant filamentous helper phage which has retained the gene III promoter, whereas the gene III encoding sequence is deleted. Amplification of phage titer of 10.sup.6 times were achieved in M13-derived phages, when used for the selection of specific antibody.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: February 22, 2000
    Assignee: Bioinvent International AB
    Inventor: Carl A. K. Borrebaeck
  • Method of selecting specific bacteriophages
    Patent number: 5712089
    Abstract: A method for selecting a molecule such as an antibody, antigen, peptide, protein or fragment thereof, which molecule is expressed together with a phage coat protein on the phage's surface. The method is characterised by linking phage replication to recognition of the molecule on the surface of the phage. The linkage can be achieved by use of a fusion protein between phage protein 3 and a specific binding ligand for the molecule.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: January 27, 1998
    Assignee: Bioinvent International AB
    Inventors: Carl A. K. Borrebaeck, Marta Duenas